Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK: Spotlit HFEA receives DoH endorsement:

This article was originally published in Clinica

Executive Summary

The UK's Department of Health has re-appointed Suzi Leather to chair the Human Fertilisation and Embryology Authority (HFEA), in a move that is a significant endorsement of Ms Leather's leadership. This includes her handling of criticism of the body's operational policy and of the debate surrounding some ground-breaking - and ethically highly sensitive - technical developments. These include therapeutic cloning and pre-implantation genetic screening for tissue-typing purposes (see Clinica No 1142, p 7). Her appointment for a second three-year term is also significant in that she will oversee the completion of major reforms in the UK's regulation of human tissue, embryology and fertility services, with the replacement of the HFEA and the Human Tissue Authority by the Regulatory Authority for Fertility and Tissue (RAFT), by April 2008 (see Clinica No 1134, p 5).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054501

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel